ProfileGDS4718 / 219156_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 83% 82% 83% 82% 85% 73% 77% 85% 81% 87% 87% 82% 80% 74% 76% 85% 90% 74% 80% 71% 83% 84% 88% 86% 82% 81% 85% 71% 83% 75% 83% 75% 82% 87% 81% 79% 79% 83% 85% 87% 86% 75% 79% 78% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.2919883
GSM549102patient 115, normal, homogenized [OPG study]7.9845382
GSM549104patient 119, normal, homogenized [OPG study]8.3336183
GSM549108patient 138, normal, homogenized [OPG study]8.0167982
GSM549119patient 077, normal, homogenized [OPG study]8.4269285
GSM549133patient 032, cancer, homogenized [OPG study]7.2707473
GSM549139patient 042, cancer, homogenized [OPG study]7.5607977
GSM549099patient 107, normal, homogenized [OPG study]8.485
GSM549109patient 139, normal, homogenized [OPG study]7.9425181
GSM549110patient 046, normal, homogenized [OPG study]8.7678387
GSM549114patient 063, normal, homogenized [OPG study]8.8043687
GSM549122patient 082, normal, homogenized [OPG study]8.1052682
GSM549134patient 033, cancer, homogenized [OPG study]7.8449880
GSM549136patient 036, cancer, homogenized [OPG study]7.3282774
GSM549140patient 044, cancer, homogenized [OPG study]7.4774176
GSM549111patient 047, normal, homogenized [OPG study]8.5749185
GSM549113patient 057, normal, homogenized [OPG study]9.4179490
GSM549132patient 031, cancer, homogenized [OPG study]7.2969374
GSM549137patient 038, cancer, homogenized [OPG study]7.897880
GSM549142patient 047, cancer, homogenized [OPG study]6.909171
GSM549100patient 110, normal, homogenized [OPG study]8.1329183
GSM549107patient 135, normal, homogenized [OPG study]8.4326784
GSM549115patient 068, normal, homogenized [OPG study]9.054988
GSM549116patient 072, normal, homogenized [OPG study]8.7199986
GSM549120patient 078, normal, homogenized [OPG study]8.1099782
GSM549131patient 030, cancer, homogenized [OPG study]8.1360781
GSM549118patient 074, normal, homogenized [OPG study]8.4996885
GSM549129patient 027, cancer, homogenized [OPG study]7.0098771
GSM549123patient 088, normal, homogenized [OPG study]8.2702383
GSM549124patient 006, cancer, homogenized [OPG study]7.3110375
GSM549126patient 015, cancer, homogenized [OPG study]8.1366883
GSM549128patient 025, cancer, homogenized [OPG study]7.4071875
GSM549103patient 117, normal, homogenized [OPG study]7.9053582
GSM549117patient 073, normal, homogenized [OPG study]8.8992187
GSM549138patient 041, cancer, homogenized [OPG study]8.0195781
GSM549141patient 045, cancer, homogenized [OPG study]7.8662179
GSM549130patient 028, cancer, homogenized [OPG study]7.6704379
GSM549101patient 111, normal, homogenized [OPG study]8.1153783
GSM549105patient 128, normal, homogenized [OPG study]8.3563385
GSM549106patient 134, normal, homogenized [OPG study]8.8955887
GSM549112patient 048, normal, homogenized [OPG study]8.6527186
GSM549125patient 011, cancer, homogenized [OPG study]7.3351275
GSM549127patient 024, cancer, homogenized [OPG study]7.8092579
GSM549135patient 035, cancer, homogenized [OPG study]7.6982778